Skip to main content
PMC home page
Heart logoLink to Heart
. 1999 May;81(5):488–494. doi: 10.1136/hrt.81.5.488

High apolipoprotein AI concentrations are associated with lower mortality and myocardial infarction five years after coronary artery bypass graft surgery

J Skinner 1, M Farrer 1, C Albers 1, H Neil 1, P Adams 1
PMCID: PMC1729029  PMID: 10212166

Abstract

OBJECTIVE—To examine mortality and myocardial infarction five years after coronary artery bypass graft (CABG) surgery and the association with different lipid fractions and haemostatic, glycaemic, and demographic risk factors.
SETTING—A regional cardiothoracic centre, Freeman Hospital, and the University Clinical Investigation Unit, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
DESIGN—353 consecutive patients (297 male, mean age 57.2 years) undergoing first time CABG for stable angina were recruited to a prospective cohort study and studied to five years.
MAIN OUTCOME MEASURES—All cause mortality, late cardiac mortality (beyond 30 days) alone and in combination with non-fatal myocardial infarction. Risk factor assessments before operation and 3, 6, 12, 24, and 60 months after surgery. For each laboratory variable a weighted mean for the period of exposure was calculated from the concentration at each time interval and the time between measurements. The distribution was divided into tertiles.
RESULTS—41 patients died (16 late cardiac deaths) and eight had a myocardial infarct. An adverse outcome occurred more frequently in the lower tertile of weighted apolipoprotein AI compared with the upper tertile. An adverse outcome was also more common in patients in the upper tertile of weighted total white blood cell count and less consistently so in patients in the upper tertile of the haemostatic covariates, factor VIIc and factor VIIIc. There was no association with other lipid fractions except for total mortality and apolipoprotein B (owing to low levels in five patients with carcinoma).
CONCLUSIONS—Low apolipoprotein AI concentrations, but no other markers of an adverse lipid profile, were associated with mortality and myocardial infarction five years after CABG. Apolipoprotein AI is associated with paraoxonase, an enzyme located on high density lipoprotein, which may limit the oxidation of low density lipoprotein. An association between outcome and other covariates such as white cell count provides a credible pointer to inflammation mediating a component of cardiovascular risk.


Keywords: coronary artery bypass graft surgery; mortality; myocardial infarction; apolipoprotein AI

Full Text

The Full Text of this article is available as a PDF (128.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler D. S., Goldman L., O'Neil A., Cook E. F., Mudge G. H., Jr, Shemin R. J., DiSesa V., Cohn L. H., Collins J. J., Jr Long-term survival of more than 2,000 patients after coronary artery bypass grafting. Am J Cardiol. 1986 Aug 1;58(3):195–202. doi: 10.1016/0002-9149(86)90046-9. [DOI] [PubMed] [Google Scholar]
  2. Blankenhorn D. H., Kramsch D. M. Reversal of atherosis and sclerosis. The two components of atherosclerosis. Circulation. 1989 Jan;79(1):1–7. doi: 10.1161/01.cir.79.1.1. [DOI] [PubMed] [Google Scholar]
  3. Blankenhorn D. H., Nessim S. A., Johnson R. L., Sanmarco M. E., Azen S. P., Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA. 1987 Jun 19;257(23):3233–3240. [PubMed] [Google Scholar]
  4. Blumlein S. L., Anderson A. J., Barboriak J. J., Rimm A. A., Walker J., Flemma R. Preoperative risk factors and aorta-coronary bypass graft patency. J Thorac Cardiovasc Surg. 1976 Nov;72(5):778–783. [PubMed] [Google Scholar]
  5. Campeau L., Enjalbert M., Lespérance J., Bourassa M. G., Kwiterovich P., Jr, Wacholder S., Sniderman A. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N Engl J Med. 1984 Nov 22;311(21):1329–1332. doi: 10.1056/NEJM198411223112101. [DOI] [PubMed] [Google Scholar]
  6. Castellani L. W., Navab M., Van Lenten B. J., Hedrick C. C., Hama S. Y., Goto A. M., Fogelman A. M., Lusis A. J. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles. J Clin Invest. 1997 Jul 15;100(2):464–474. doi: 10.1172/JCI119554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Castelli W. P., Garrison R. J., Wilson P. W., Abbott R. D., Kalousdian S., Kannel W. B. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 1986 Nov 28;256(20):2835–2838. [PubMed] [Google Scholar]
  8. Daida H., Yokoi H., Miyano H., Mokuno H., Satoh H., Kottke T. E., Hosoda Y., Yamaguchi H. Relation of saphenous vein graft obstruction to serum cholesterol levels. J Am Coll Cardiol. 1995 Jan;25(1):193–197. doi: 10.1016/0735-1097(94)00341-m. [DOI] [PubMed] [Google Scholar]
  9. Farrer M., Skinner J. S., Albers C. J., Alberti K. G., Adams P. C. Outcome after coronary artery surgery in women and men in the north of England. QJM. 1997 Mar;90(3):203–211. doi: 10.1093/qjmed/90.3.203. [DOI] [PubMed] [Google Scholar]
  10. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed] [Google Scholar]
  11. Garfagnini A., Devoto G., Rosselli P., Boggiano P., Venturini M. Relationship between HDL-cholesterol and apolipoprotein A1 and the severity of coronary artery disease. Eur Heart J. 1995 Apr;16(4):465–470. doi: 10.1093/oxfordjournals.eurheartj.a060937. [DOI] [PubMed] [Google Scholar]
  12. Gillum R. F., Fortmann S. P., Prineas R. J., Kottke T. E. International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J. 1984 Jul;108(1):150–158. doi: 10.1016/0002-8703(84)90558-1. [DOI] [PubMed] [Google Scholar]
  13. Lawrie G. M., Morris G. C., Jr, Earle N. Long-term results of coronary bypass surgery. Analysis of 1698 patients followed 15 to 20 years. Ann Surg. 1991 May;213(5):377–387. doi: 10.1097/00000658-199105000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lindén T., Bondjers G., Karlsson T., Wiklund O. Serum triglycerides and HDL cholesterol--major predictors of long-term survival after coronary surgery. Eur Heart J. 1994 Jun;15(6):747–752. doi: 10.1093/oxfordjournals.eurheartj.a060581. [DOI] [PubMed] [Google Scholar]
  15. Liuzzo G., Biasucci L. M., Gallimore J. R., Grillo R. L., Rebuzzi A. G., Pepys M. B., Maseri A. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med. 1994 Aug 18;331(7):417–424. doi: 10.1056/NEJM199408183310701. [DOI] [PubMed] [Google Scholar]
  16. Loop F. D., Golding L. R., MacMillan J. P., Cosgrove D. M., Lytle B. W., Sheldon W. C. Coronary artery surgery in women compared with men: analyses of risks and long-term results. J Am Coll Cardiol. 1983 Feb;1(2 Pt 1):383–390. doi: 10.1016/s0735-1097(83)80064-3. [DOI] [PubMed] [Google Scholar]
  17. Mackness M. I., Mackness B., Durrington P. N., Connelly P. W., Hegele R. A. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol. 1996 Apr;7(2):69–76. doi: 10.1097/00041433-199604000-00004. [DOI] [PubMed] [Google Scholar]
  18. Pocock S. J., Shaper A. G., Phillips A. N. Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease. BMJ. 1989 Apr 15;298(6679):998–1002. doi: 10.1136/bmj.298.6679.998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rader D. J., Hoeg J. M., Brewer H. B., Jr Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Ann Intern Med. 1994 Jun 15;120(12):1012–1025. doi: 10.7326/0003-4819-120-12-199406150-00008. [DOI] [PubMed] [Google Scholar]
  20. Rahimtoola S. H., Fessler C. L., Grunkemeier G. L., Starr A. Survival 15 to 20 years after coronary bypass surgery for angina. J Am Coll Cardiol. 1993 Jan;21(1):151–157. doi: 10.1016/0735-1097(93)90730-o. [DOI] [PubMed] [Google Scholar]
  21. Ridker P. M., Cushman M., Stampfer M. J., Tracy R. P., Hennekens C. H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997 Apr 3;336(14):973–979. doi: 10.1056/NEJM199704033361401. [DOI] [PubMed] [Google Scholar]
  22. Santoian E. D., Schneider J. E., Gravanis M. B., Foegh M., Tarazona N., Cipolla G. D., King S. B., 3rd Angiopeptin inhibits intimal hyperplasia after angioplasty in porcine coronary arteries. Circulation. 1993 Jul;88(1):11–14. doi: 10.1161/01.cir.88.1.11. [DOI] [PubMed] [Google Scholar]
  23. Santoian E. D., Schneider J. E., Gravanis M. B., Foegh M., Tarazona N., Cipolla G. D., King S. B., 3rd Angiopeptin inhibits intimal hyperplasia after angioplasty in porcine coronary arteries. Circulation. 1993 Jul;88(1):11–14. doi: 10.1161/01.cir.88.1.11. [DOI] [PubMed] [Google Scholar]
  24. Sigurdsson G., Baldursdottir A., Sigvaldason H., Agnarsson U., Thorgeirsson G., Sigfusson N. Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. Am J Cardiol. 1992 May 15;69(16):1251–1254. doi: 10.1016/0002-9149(92)91215-p. [DOI] [PubMed] [Google Scholar]
  25. Skinner J. S., Farrer M., Albers C. J., Piper K., Neil H. A., Adams P. C. Serum Lp(a) lipoprotein concentration is not associated with clinical and angiographic outcome five years after coronary artery bypass graft surgery. Heart. 1997 Aug;78(2):131–135. doi: 10.1136/hrt.78.2.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Soeldner J. S., Slone D. Critical variables in the radioimmunoassay of serum insulin using the double antibody technic. Diabetes. 1965 Dec;14(12):771–779. doi: 10.2337/diab.14.12.771. [DOI] [PubMed] [Google Scholar]
  27. Ståhle E., Bergström R., Holmberg L., Edlund B., Nyström S. O., Sjögren I., Hansson H. E. Survival after coronary artery bypass grafting. Experience from 4661 patients. Eur Heart J. 1994 Sep;15(9):1204–1211. doi: 10.1093/oxfordjournals.eurheartj.a060654. [DOI] [PubMed] [Google Scholar]
  28. Thompson S. G., Kienast J., Pyke S. D., Haverkate F., van de Loo J. C. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med. 1995 Mar 9;332(10):635–641. doi: 10.1056/NEJM199503093321003. [DOI] [PubMed] [Google Scholar]
  29. Varnauskas E. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med. 1988 Aug 11;319(6):332–337. doi: 10.1056/NEJM198808113190603. [DOI] [PubMed] [Google Scholar]
  30. Watson A. D., Berliner J. A., Hama S. Y., La Du B. N., Faull K. F., Fogelman A. M., Navab M. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest. 1995 Dec;96(6):2882–2891. doi: 10.1172/JCI118359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yasue H., Takizawa A., Nagao M., Nishida S., Horie M., Kubota J., Omote S., Takaoka K., Okumura K. Long-term prognosis for patients with variant angina and influential factors. Circulation. 1988 Jul;78(1):1–9. doi: 10.1161/01.cir.78.1.1. [DOI] [PubMed] [Google Scholar]
  32. Yli-Mäyry S., Huikuri H. V. Clinical and angiographic prediction of myocardial infarction and recurrence of severe angina during a five-year follow-up after coronary artery bypass grafting. Am J Cardiol. 1993 Dec 15;72(18):1371–1375. doi: 10.1016/0002-9149(93)90182-c. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES